Angiex Inc.
Research - Cambridge, Massachusetts, US
Angiex Inc. Details
Angiex Inc. is a privately held biotech startup whose mission is to exploit newly discovered biological transport mechanisms to make drugs with revolutionary power over cancer. Based in Cambridge, Mass., Angiex was founded by a scientific team of leading experts in angiogenesis, vascular biology, and oncology. The company is developing a novel portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus or cytosol, where the site of payload action is located.
Website:
https://angiex.com
Employees:
15
HQ:
(617) 576-1753
Location:
Cambridge, Massachusetts, US
Revenue:
$6 million
Angiex Inc. Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Other
Mobile Friendly